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RecyclingAbstract A simple, efﬁcient, and ecofriendly method has been developed for the exclusive synthe-
sis of iron oxide nanoparticles using an aqueous extract of Passiﬂora tripartita var. mollissima fruit.
Transmission electron microscopy (TEM) and Dynamic Light Scattering (DLS) analysis show that
the average particle size of spherical iron oxide nanoparticles is 22.3 ± 3 nm. The synthesized nan-
ocatalyst is highly active for the synthesis of biologically signiﬁcant 2-arylbenzimidazoles. The reac-
tion was carried out under mild condition with excellent yields. The catalyst is easily separated by
magnet and recyclable without signiﬁcant loss of activity.
ª 2014 King Saud University. Production and hosting by Elsevier B.V.D license.1. Introduction
The primary interest of researchers from chemistry, physics,
industry, medicine, biology and material science toward nano-
technology is the improvement of production methods, espe-
cially those that are simpler and cleaner. The objectives are
the production of size-controlled clusters, increasing the yield
of desirable nanoparticles, and the reduction of the subsequent
pollutant contribution. Additionally, iron oxides have at-
tracted a great deal of attention among specialists because of
their multifunctional properties such as small size, high magne-
tism and low toxicity [4] and microwave absorption properties
[15]. These materials have a considerable potential to be ap-plied as sensors, in catalysis [24], as high-density magnetic
recording media [21], for targeted drug delivery in clinical trials
[17], and as substrates in cancer treatment methods [16]. The
application of these nanostructures in medicine involves major
requirements because oxide nanoparticles must be super para-
magnetic, with a discrete distribution and narrow size distribu-
tion in a range smaller than 20 nm, which is a condition for
maintaining these particular physical and chemical properties
[10,26,2]. A wide variety of methods have been reported in
the literature for the synthesis of Fe3O4 nanoparticles such
as hydrothermal process [13], sonochemical method [14], mi-
cro-emulsion technique [6], electrochemical route [7] and co-
precipitation method [25]. The literature survey reveals that
some of the reports are in availability on green synthesis of
Fe3O4 nanoparticles [3,18,22,12,5]. Nowadays, synthesis of
iron oxide nanoparticles using phytochemicals has attracted
much attention due to their simplicity, environmental benigni-
ty and low cost.
Recent advances in Nanoscience and nanotechnology have
also led to the development of an efﬁcient synthesis of
bioactive compounds using nanoparticles in an ecologically
and economically favorable way which is a great challenge in
Figure 1 Ferric chloride solution (A) and iron oxide nanopar-
ticles (B).
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isostere of naturally occurring nucleotides; hence, it has been
useful intermediates in the development of molecules of
pharmaceutical and biological interests. Substituted benzimid-
azole derivatives have found applications in diverse
therapeutic areas including anti-hepatitis, anti ulcers, antihy-
pertensives, antivirals, antifungals, anticancer, and antihista-
mines [9,1,23].
In continuation of our ongoing research on the synthesis of
2-aryl-1-arylmethyl-1H-benzimidazoles [19,20], herein we re-
port the use of a convenient, mild and efﬁcient reagent for
the preparation of 2-arylbenzimidazoles from o-phenylenedi-
amine and aryl aldehydes in acetonitrile solvent at room
temperature.
To the best of our knowledge, no one has been reported
Passiﬂora tripartita mediated synthesis of iron oxide nanopar-
ticles and have been utilized for synthesis of 2-arylbenzimidaz-
oles at room temperature.
2. Experimental
2.1. Materials
The yellow P. tripartita (TAXO) fruit used in this experiment
was fresh, ripened, and was purchased from the local market
Sangolqui, near Universidad de las Fuerzas Armadas (ESPE),
Ecuador. Ferric Chloride (FeCl3.6H2O, 99.0%) was purchased
from Sigma Aldrich, USA. The water used in all experiments
was doubly distilled.
2.2. Characterization
The synthesized iron oxide nanoparticles were characterized
with the help of a UV–Vis spectrophotometer (Thermospec-
tronic, GENESYS 8).The size of nanoparticles was analyzed
by using Dynamic Light Scattering instrument (HORIBA LB-
550). Transmission electron microscopy was performed in sup-
port ﬁlm of 2% polyvinyl formal solution stabilized with car-
bon. Brieﬂy, TEM images were recorded digitally (FEI Tecnai
G2 spirit twin). FTIR analysis was carried out to determine the
functional groups present in P. tripartite extract and their pos-
sible involvement in the synthesis of Fe3O4 nanoparticles. The
FTIR-ATR spectra were collected in the transmission mode
(4000–650 cm1) using a Perkin Elmer spectrophotometer
(FTIR Spectrum Two). X-ray diffraction (XRD) studies on
thin ﬁlms of the nanoparticle were carried out using a BRU-
KER D8 ADVANCE brand h-2h conﬁguration (generator-
detector) X-ray tube copper k= 1.54 A and LYNXEYE
PSD detector. 1H and 13C NMR spectra of CDCl3 solutions
were obtained with an Advance 500 (Model: Bruker, 11.4 Te-
sla, 500 MHz) spectrometer using tetramethylsilane (TMS) as
the internal standard to characterize 2-arylbenzimidazole
derivatives. ESI-MS were obtained on a Varian 91 500-LC
ion trap mass spectrometer. Melting points determined on a
digital Stuart SMP 10 melting point apparatus (ST15, OSA,
UK) are uncorrected. The thin layer chromatography (TLC)
was performed using the aluminum sheets coated with silica
gel 60 (MERCK) containing ﬂuorescent indicators, F254.
The solvent for the development of the TLC plate was hexane:
ethyl acetate (7:3).2.3. Preparation of P. tripartita fruit extract
A 25 g of thoroughly washed P. tripartita fruit was chopped ﬁ-
nely, and sonication in 70 ml mixture of methanol and double
distilled water (1/1) for 10 min. The yellow extract was ﬁltered
through a Whatmann ﬁlter paper No. 2. The clear ﬁltrate was
used for the synthesis of iron nanoparticles and stored at 4 C
for further experiments.
2.4. General procedure for the preparation of the iron oxide
nanoparticles
In a typical reaction procedure, 20 ml of P. tripartita extract
was added to 270 mg of FeCl3.6H2O (1 mmol) and pH is ad-
justed to 8, using 0.1 M NaOH solution, then the solution
was placed under vigorous magnetic stirring for 4 h at 80 C.
During this process, the color of the reaction solution changed
from yellowish translucent to a blackish color as shown in
Fig. 1, indicating the formation of iron oxide (Fe3O4) nanopar-
ticles. The resulting product, iron nanoparticle was centrifuged
at 7000 rpm for 15 · 2 min and washed several times with 1:1
mixtures of distilled water, and absolute methanol. The Puri-
ﬁed nanoparticle powder was dried at 90 C for 16 h and
stored in an airtight bottle for further characterization by
TEM, DLS, FTIR and XRD.
The following equation shows the formation of Fe3O4
nanoparticles.
Fe3þ þ 3H2O ! FeðOHÞ3 # þ3Hþ
FeðOHÞ3 # þFlavonoidsGlycoside’s
! Fe3O4 nanoparticlesþ Carbonic acid2.5. General procedure for the synthesis of 2-arylbenzimidazoles
in the presence of iron nanoparticles
A mixture of the corresponding aldehyde (1 mmol), iron oxide
nanoparticles (20 mg), o-phenylenediamine (1 mmol) and ace-
tonitrile (10 ml) was stirred for 45 min as shown in Fig. 2.
The progress of the reaction was monitored by TLC. After
cooling to room temperature, the residue was puriﬁed by
chromatography on silica gel using ethyl acetate as eluent.
Figure 2 Scheme for synthesis of 2-arylbenzimidazoles.
Figure 3 UV–Vis spectrum of P. tripartita water extracts and
iron oxide nanoparticles.
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mass spectrum analysis and 1H NMR proton signals.
2.5.1. 2-(2-Chlorophenyl) -1H-benzimidazole
C13H9ClN2; White solid (80%); mp 230–232 C; 1H NMR
(500 MHz, CDCl3): d 8.40 (dd, 1H), 7.68 (br, 2H), 7.48 (m,
1H), 7.40 (m, 2H), 7.31 (m, 2H); ESI-MS:m/z= 229.1 (M+1).
3. Results and discussion
The role of the P. tripartita extracts containing phytochemi-
cals as ﬂavonoids in the nanoparticle formation process wasFigure 4 FTIR spectrum of P. tripartita extrclariﬁed through change of color from yellowish translucent
to blackish (Fig. 1). UV–Vis absorption spectra of an aque-
ous solution of the P. tripartita extracts observed in both
the absence and presence of Fe3+. The results are depicted
in Fig. 3, it is clear that the absorbance of P. tripartita ex-
tracts is altered signiﬁcantly and interacts with the Fe3+.
The interactions between the Fe3+ precursor and P. tripar-
tita extracts, and iron oxide nanoparticles were further con-
ﬁrmed by FTIR. Fig. 4 explains the FTIR spectra of the
iron oxide nanoparticles prepared using P. tripartita extract.
The peaks at 2946, 2834, 1654 cm1 because of –CH2–, and
–C‚O groups can be seen in the FTIR spectra of
P. tripartita extracts (Fig. 4A), indicating the presence of
methyl and carbonyl groups. A broad peak at 3326 cm1
was observed, which may be assigned to –OH, hydroxyl
groups present in P. tripartita extracts. The FTIR spectrum
of iron oxide nanoparticles shows bands at 3308–3105 and
1626 cm1 corresponding to O–H stretching and bending
bands (Fig. 4B). The strong band of iron oxide
nanoparticles shifted at low frequency, is due to the involve-
ment of –OH, –C‚O in binding and conﬁrming the
involvement of hydroxyl and carbonyl groups of P. triparti-
ta for the synthesis of nanoparticles. The corresponding
adsorption frequencies at low wave numbers (<700 cm1)
come from vibrations of Fe–O bonds of iron oxide. The
presence of organic groups on the surface of iron oxide
nanoparticles could enhance the hydrophobicity of
nanoparticle which is favorable for applications in hydro-
phobic solvents and preventing aggregation of iron oxide
nanoparticles or uncontrolled growth.acts (A) and iron oxide nanoparticles (B).
50 nm 20 nm 
Figure 5 TEM image of the iron oxide nanoparticles.
Figure 6 DLS image showing the distribution of the iron oxide
nanoparticles (the average particle size = 22.3 ± 3 nm/
0.022 ± 3 lm).
Figure 7 XRD patterns of Fe3O4 nanoparticles.
Figure 8 Magnetization curves of Fe3O4 nanoparticles.
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nanoparticles were well dispersed in colloidal solution with
spherical particles ranging from 18.23 to 24.65 nm. No ef-
fects on the particle size and their dispersion on dilution
of nanoparticle suspension were shown. The average sizeof iron nanoparticles observed in Dynamic Light Scattering
(DLS) is about 22.3 ± 3 nm as shown in Fig. 6. The crystal-
line nature of Fe3O4 nanoparticles is conﬁrmed from XRD
analysis as shown in Fig. 7. It is found that all reﬂection
peaks at 2h= 30.1 (220), 35.4 (311), 43.3 (400), 53.4
(422) and 56.7 (511) which are sharper coincided well with
the cubic spinel phase of Fe3O4 (JCPDS card No. 19-0629).
However, the peak appearing at 41.9, 43.7 and 52. 2 are of
impurity. The magnetic properties of the as prepared iron
oxide/Fe3O4 nanoparticles are studied using vibrating sample
magnetometer (VSM) at room temperature. The hysteresis
loop as shown in Fig. 8, demonstrates a ferromagnetic
behavior with the saturation magnetization value about
13.2 emu/g.
To show the catalytic activity of iron oxide nanoparti-
cles in the synthesis of 2-arylbenzimidazoles, the reaction
of o-phenylenediamine (1 mmol) with various types of aro-
matic aldehydes (1 mmol) with electron donating and elec-
tron withdrawing substituents was carried out (Fig. 2).
The corresponding 2-arylbenzimidazoles were compared
with reported [11,8] and obtained in 80–45% yields (Ta-
ble 1). The reusability of the catalyst was investigated in
Table 1 Iron nanoparticle catalyzed selective synthesis of 2-arylbenzimidazole derivatives. The literature melting points are given in
parentheses.
Entry Aldehyde (2) Product (3) Time for stirring (min) Yield (%) mp, C (Obs.)
1 CHO
Cl
3a
45 80 230–232
2 CHO
OH
3b
60 45 225–227
3 CHO
Cl
3c
45 85 289–291
4 CHO
OCH3
3d
45 58 232–234
5 CHO
H3C
3e
45 55 263–265
6 CHO 3f 45 80 288–290
7 CHO
H3CO
3g 45 60 224–226
368 B. Kumar et al.the reaction of benzaldehyde with o-phenylenediamine.
The iron nanoparticles were recovered by using magnetic
separation and washed with EtOH and dried in an oven
at 100 C for 3 h. The recovered catalyst was reused for
further four times and the reaction proceeded smoothly
with a yield of >95% (Fig. 9). These results indicate that
the catalyst is reusable with moderate declining in its
activity.
4. Conclusions
In conclusion, we have synthesized iron oxide nanoparticles
(Fe3O4) using P. tripartita and studied their catalytic effect
for the synthesis of 2-arylbenzimidazole under room tempera-
ture. The ecofriendly synthesized Fe3O4 nanoparticles werecharacterized by UV–Vis, TEM, DLS, FTIR and XRD data.
The TEM pictures showed Fe3O4 nanoparticles of below
25 nm in diameter with spherical shape. The one-pot synthesis
of 2-arylbenzimidazole derivatives using Fe3O4 nanoparticles
is environmentally benign, selective and easy to manipulate.
In addition, the Fe3O4 nanoparticles as a heterogeneous cata-
lyst could be reused ﬁve times for fresh reactions with slight
loss of activity.Acknowledgements
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